Skip to main content
. 2026 Mar 2;34:e20250618. doi: 10.1590/1678-7765-2025-0618

Table 2. Clinical and demographic characteristics of the patients from TCGA-OTSCC cohort and the results of the Univariate and Multivariable Cox proportional hazards regression analyses.

Univariable Cox Regression  
Clinicopathological Characteristics Overall Survival Disease-Free Survival
  n p-value HR (95% CI) PH n p-value HR (95% CI) PH
CCNA2 128 0.02 1.0003 1.000-1.0005 0.407 128 0.02 1.000 1.00-1.001 0.424
Age 128 0.51 1.008 0.98-1.03 0.907 101 0.82 1.003 0.97-1.02 0.413
Sex                    
Male 83 Reference       68 Reference      
Female 45 0.66 1.138 0.638-2.031 0.441 33 0.47 0.763 0.37-1.59 0.364
AJCC TNM Stage                    
I-II 34 Reference       30 Reference      
III-IV 82 0.07 2.000 0.92 – 4.32 0.846 62 0.70 1.154 0.54-2.45 0.114
AJCC T Stage                    
I-II 67 Reference       58 Reference      
III-IV 53 0.0004 3.018 1.62-5.61 0.949 37 0.12 1.711 0.86-3.39 0.077
AJCC N Stage                    
N0 51 Reference       45 Reference      
I-II 63 0.09 1.725 0.90-3.28 0.894 47 0.55 1.236 0.60-2.50 0.869
Grade                    
I 17 Reference       13 Reference      
II-III 111 0.26 1.794 0.63-5.05 0.008 88 0.16 2.738 0.65-11.41 0.701
Pharmaceutical Adjuvant                    
No 26 Reference       22 Reference      
Yes 7 0.18 2.346 0.66-8.33 0,146 6 0.35 1.928 0.48-7.73 0.972
Radiation Adjuvant                    
No 16 Reference       13 Reference      
Yes 19 0.21 2.313 0.61-8.72 0.994 17 0.16 3.015 0.63-14.22 0.571
Multivariable Cox Regression Model  
Clinicopathological Characteristics Overall Survival Disease-Free Survival
  n p-value HR (95% CI) PH n p-value HR (95% CI) PH
CCNA2 120 0.011 1.000 1.00-1.001 0.541 95 0.03 1.000 1.00-1.001 0.588
AJCC T Stage                    
III-IV 120 0.0003 3.18 1.69-5.98 0.946 95 0.099 1.787 0.89-3.56 0.082